Serveur d'exploration COVID et hydrochloroquine - Corpus (Accueil)

Index « ISSN » - entrée « 1873-0442 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
1873-0183 < 1873-0442 < 1873-1244  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000123 (2021) Joshuan J. Barboza ; Diego Chambergo-Michilot ; Mariana Velasquez-Sotomayor ; Christian Silva-Rengifo ; Carlos Diaz-Arocutipa ; Jose Caballero-Alvarado ; Franko O. Garcia-Solorzano ; Christoper A. Alarcon-Ruiz ; Leonardo Albitres-Flores ; German Malaga ; Patricia Schlagenhauf ; Alfonso J. Rodriguez-MoralesAssessment and management of asymptomatic COVID-19 infection: A systematic review.
000276 (2021) Fabricio Souza NevesCorrelation of the rise and fall in COVID-19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis.
000380 (2021) Stéphane Honoré ; Philippe GautretReply to Alizazgar J. Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
000668 (2021) Matthieu Million ; Audrey Giraud-Gatineau ; Jean-Christophe Lagier ; Philippe Parola ; Philippe Gautret ; Didier RaoultReply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin.
000903 (2020) Silvia Nunes Szente Fonseca ; Anastasio De Queiroz Sousa ; Alexandre Giandoni Wolkoff ; Marcelo Sampaio Moreira ; Bruno Castro Pinto ; Christianne Fernandes Valente Takeda ; Eduardo Rebouças ; Ana Paula Vasconcellos Abdon ; Anderson L A. Nascimento ; Harvey A. RischRisk of hospitalization for Covid-19 outpatients treated with various drug regimens in Brazil: Comparative analysis.
000B44 (2020) Jean Joel Bigna ; Joseph Kamtchum-Tatuene ; Jean Jacques NoubiapClaims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence.
000B79 (2020) Javad AlizargarDangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.
000C42 (2020) Mathieu Gendrot ; Julien Andreani ; Manon Boxberger ; Priscilla Jardot ; Isabelle Fonta ; Marion Le Bideau ; Isabelle Duflot ; Joel Mosnier ; Clara Rolland ; Hervé Bogreau ; Sébastien Hutter ; Bernard La Scola ; Bruno PradinesAntimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation.
000C87 (2020) Aimé Bonny ; Mohammed A. Talle ; Marcus Ngantcha ; Muzahir H. TayebjeeConflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
001011 (2020) Maria Mazzitelli ; Chiara Davoli ; Vincenzo Scaglione ; Paolo Fusco ; Valentina La Gamba ; Giovanni Matera ; Enrico Maria Trecarichi ; Carlo TortiApparent inefficacy of hydroxychloroquine combined with azithromycin on SARS-CoV-2 clearance in an incident cohort of geriatric patients with COVID-19.
001192 (2020) Khalid Eljaaly ; Kasim Huseein Alireza ; Samah Alshehri ; Jaffar A. Al-TawfiqHydroxychloroquine safety: A meta-analysis of randomized controlled trials.
001222 (2020) David Lebeaux ; Matthieu RevestNo evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France".
001288 (2020) Jean-Christophe Lagier ; Matthieu Million ; Philippe Gautret ; Philippe Colson ; Sébastien Cortaredona ; Audrey Giraud-Gatineau ; Stéphane Honoré ; Jean-Yves Gaubert ; Pierre-Edouard Fournier ; Hervé Tissot-Dupont ; Eric Chabrière ; Andreas Stein ; Jean-Claude Deharo ; Florence Fenollar ; Jean-Marc Rolain ; Yolande Obadia ; Alexis Jacquier ; Bernard La Scola ; Philippe Brouqui ; Michel Drancourt ; Philippe Parola ; Didier RaoultOutcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
001406 (2020) Lucie Pothen ; Halil Yildiz ; Julien De Greef ; Andrea Penaloza ; Christophe Beauloye ; Leila Belkhir ; Jean Cyr YombiSafe use of hydroxychloroquine and its combination with azithromycin in the context of Sars-CoV-2 outbreak: Clinical experience in a Belgian tertiary center.
001526 (2020) Corneliu P. Popescu ; Philip R. FischerHydroxychloroquine-azithromycin for COVID-19 - Warranted or dangerous?
001752 (2020) Anwar M. Hashem ; Badrah S. Alghamdi ; Abdullah A. Algaissi ; Fahad S. Alshehri ; Abdullah Bukhari ; Mohamed A. Alfaleh ; Ziad A. MemishTherapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
001753 (2020) Matthieu Million ; Jean-Christophe Lagier ; Philippe Gautret ; Philippe Colson ; Pierre-Edouard Fournier ; Sophie Amrane ; Marie Hocquart ; Morgane Mailhe ; Vera Esteves-Vieira ; Barbara Doudier ; Camille Aubry ; Florian Correard ; Audrey Giraud-Gatineau ; Yanis Roussel ; Cyril Berenger ; Nadim Cassir ; Piseth Seng ; Christine Zandotti ; Catherine Dhiver ; Isabelle Ravaux ; Christelle Tomei ; Carole Eldin ; Hervé Tissot-Dupont ; Stéphane Honoré ; Andreas Stein ; Alexis Jacquier ; Jean-Claude Deharo ; Eric Chabrière ; Anthony Levasseur ; Florence Fenollar ; Jean-Marc Rolain ; Yolande Obadia ; Philippe Brouqui ; Michel Drancourt ; Bernard La Scola ; Philippe Parola ; Didier RaoultEarly treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
001811 (2020) Natalia Rodriguez-Valero ; Isabel Vera ; Montse Roldan Torralvo ; Teresa De Alba ; Elisabeth Ferrer ; Daniel Camprubi ; Alex Almuedo Riera ; Ruth Sotil Gallego ; Magdalena Muelas ; Maria Jesus Pinazo ; Jose Mu OzMalaria prophylaxis approach during COVID-19 pandemic.
001881 (2020) Giuseppe MagroSARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies?
001982 (2020) Philippe Gautret ; Jean-Christophe Lagier ; Philippe Parola ; Van Thuan Hoang ; Line Meddeb ; Jacques Sevestre ; Morgane Mailhe ; Barbara Doudier ; Camille Aubry ; Sophie Amrane ; Piseth Seng ; Marie Hocquart ; Carole Eldin ; Julie Finance ; Vera Esteves Vieira ; Hervé Tissot Tissot-Dupont ; Stéphane Honoré ; Andreas Stein ; Matthieu Million ; Philippe Colson ; Bernard La Scola ; Véronique Veit ; Alexis Jacquier ; Jean-Claude Deharo ; Michel Drancourt ; Pierre Edouard Fournier ; Jean-Marc Rolain ; Philippe Brouqui ; Didier RaoultClinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
001A28 (2020) Patricia Schlagenhauf ; Martin P. Grobusch ; Julian D. Maier ; Philippe GautretRepurposing antimalarials and other drugs for COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Corpus
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i -k "1873-0442" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/ISSN.i  \
                -Sk "1873-0442" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Corpus
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1873-0442
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021